Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 6 Issue 1

COVID-19: The Origin

Silvere D Zaongo1* and Dieudonne Ouattara2

1Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China
2Centre de Recherche Clinique De Nanoro, Burkina Faso

*Corresponding Author: Silvere D Zaongo, Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China.

Received: November 26, 2021; Published: December 07, 2021

In December 2019, cases of the third zoonotic human coronavirus epidemic were reported in China. They triggered the curiosity of local medical officers who-in the absence of evidence showing the presence of typical pathogens-had collected lower respiratory tract samples to conduct a sharp sequencing analysis revealing (in January 2020) the presence of a novel coronavirus named SARS-CoV-2 [1]. Similarly, to severe acute respiratory syndrome coronavirus (SARS-CoV) [2-4] and Middle East respiratory syndrome coronavirus (MERS-CoV) [5,6]. SARS-CoV-2 viral pneumonia is associated with symptoms such as fever, difficulty breathing, and bilateral lung infiltration in the most severe cases [7]. SARS-CoV and MERS-CoV have caused more than 10,000 cumulative cases in the past two decades, with mortality rates of 10% for SARS-CoV and 37% for MERS-CoV [8,9]. At the time of revision of this editorial (November 26, 2021), it was established that SARS-CoV-2 alone caused more than 260,200,000 and 5,100,000 cumulative cases and deaths, respectively [10].

Keywords: COVID-19; SARS-CoV; MERS-CoV; SARS-CoV-2

References

  1. Huang C., et al. “Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China”. Lancet10223 (2020): 497-506.
  2. Ksiazek TG., et al. “A novel coronavirus associated with severe acute respiratory syndrome”. The New England Journal of Medicine20 (2003): 1953-1966.
  3. Kuiken T., et al. “Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome”. Lancet9380 (2003): 263-270.
  4. Drosten C., et al. “Identification of a novel coronavirus in patients with severe acute respiratory syndrome”. The New England Journal of Medicine20 (2003): 1967-1976.
  5. de Groot RJ., et al. “Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group”. Journal of Virology14 (2013): 7790-7792.
  6. Zaki AM., et al. “Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia”. The New England Journal of Medicine19 (2012): 1814-1820.
  7. Gralinski LE, Menachery VD. “Return of the Coronavirus: 2019-nCoV”. Viruses2 (2020): 135.
  8. World Health Organization, 2015. “Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003” (2003).
  9. World Health Organization. “Middle East respiratory syndrome coronavirus (MERS-CoV)” (2019).
  10. “COVID-19 coronavirus outbreak” (2020).
  11. National Conference of State Legislatures, 2020. “President Trump declares state of emergency for COVID-19” (2020).
  12. Jia Z., et al. “In depth: How the US missed its window for taming the covid-19 virus” (2020).
  13. Kahn N. “New virus discovered by Chinese scientists investigating pneumonia outbreak”. Wall Street Journal (2020).
  14. Cheng VC., et al. “Clinical management and infection control of SARS: lessons learned”. Antiviral Research2 (2013): 407-419.
  15. Li W., et al. “Bats are natural reservoirs of SARS-like coronaviruses”. Science 5748 (2005): 676-679.
  16. Ge XY., et al. “Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor”. Nature 7477 (2013): 535-538.
  17. Yang L., et al. “Novel SARS-like betacoronaviruses in bats, China, 2011”. Emerging Infectious Diseases 6 (20013): 989-991.
  18. Hu B., et al. “Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus”. PLoS Pathogen11 (2017): e1006698.
  19. Menachery VD., et al. “A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence”. Nature Medicine12 (2015): 1508-1513.
  20. Menachery VD., et al. “SARS-like WIV1-CoV poised for human emergence”. Proceedings of the National Academy of Sciences of the United States of America11 (2016): 3048-3053.
  21. Wang N., et al. “Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China”. Virologica Sinica1 (2018): 104-107.
  22. Zhou P., et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin”. Nature 7798 (2020): 270-273.
  23. World Health Organization. “Novel coronavirus-Japan (ex-China)” (2020).
  24. Ji W., et al. “Cross-species transmission of the newly identified coronavirus 2019-nCoV”. Journal of Medical Virology4 (2020): 433-440.
  25. Robertson D., et al. “nCoV's relationship to bat coronavirus and recombination signals no snakes (2020).
  26. Xiao K., et al. “Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins”. Nature 7815 (2020): 286-289.
  27. Guan W-j., et al. “Clinical Characteristics of Coronavirus Disease 2019 in China”. The New England Journal of Medicine18 (2020): 1708-1720.
  28. Li Q., et al. “Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia”. The New England Journal of Medicine13 (2020): 1199-1207.
  29. World Health Organization. “WHO experts to travel to China” (2020).

Citation

Citation: Silvere D Zaongo and Dieudonne Ouattara. “COVID-19: The Origin". Acta Scientific Pharmaceutical Sciences 6.1 (2022): 15-17.

Copyright

Copyright: © 2022 Silvere D Zaongo and Dieudonne Ouattara. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US